{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:41:32Z","timestamp":1789054892581,"version":"build-2803163510"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400282"],"award-info":[{"award-number":["82400282"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20269"],"award-info":[{"award-number":["U22A20269"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.metabol.2025.156332","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T11:06:10Z","timestamp":1750331170000},"page":"156332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The bone-heart axis: A crucial dialogue in cardiovascular disease"],"prefix":"10.1016","volume":"170","author":[{"given":"Ying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Zhu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2025.156332_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156084","article-title":"Reducing the global prevalence of cardiometabolic risk factors: a bet worth winning","volume":"163","author":"Fogacci","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156332_bb0010","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-8587(14)70059-2","article-title":"Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders","volume":"2","author":"Vervloet","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2025.156332_bb0015","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3389\/fendo.2020.00592","article-title":"Osteocytic FGF23 and its kidney function","volume":"11","author":"Agoro","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2025.156332_bb0020","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","article-title":"Endocrine regulation of energy metabolism by the skeleton","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2025.156332_bb0025","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2265.2011.04065.x","article-title":"Serum levels of osteocalcin are inversely associated with the metabolic syndrome and the severity of coronary artery disease in Chinese men","volume":"75","author":"Bao","year":"2011","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.metabol.2025.156332_bb0030","first-page":"37","article-title":"Bone-organ axes: bidirectional crosstalk","volume":"11","author":"Deng","year":"2024","journal-title":"Mil Med Res"},{"key":"10.1016\/j.metabol.2025.156332_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-07-0095","article-title":"The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis","volume":"194","author":"Razzaque","year":"2007","journal-title":"J Endocrinol"},{"key":"10.1016\/j.metabol.2025.156332_bb0040","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11914-013-0178-8","article-title":"Novel bone endocrine networks integrating mineral and energy metabolism","volume":"11","author":"Pi","year":"2013","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.metabol.2025.156332_bb0045","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2025.156332_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093423","article-title":"Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium","volume":"9","author":"Six","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2025.156332_bb0055","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2025.156332_bb0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13293-022-00480-w","article-title":"Sex-dependent expression of neutrophil gelatinase-associated lipocalin in aortic stenosis","volume":"13","author":"Jover","year":"2022","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.metabol.2025.156332_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116596","article-title":"Bone mass loss in chronic heart failure is associated with sympathetic nerve activation","volume":"166","author":"Guan","year":"2023","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2025.156332_bb0070","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvab187","article-title":"Changes of FGF23 and the renin-angiotensin-system in male mouse models of chronic kidney disease and cardiac hypertrophy","volume":"6","author":"Okamoto","year":"2022","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.metabol.2025.156332_bb0075","first-page":"132","article-title":"Dkk1 exacerbates doxorubicin-induced cardiotoxicity by inhibiting the Wnt\/\u03b2-catenin signaling pathway","author":"Liang","year":"2019","journal-title":"J Cell Sci"},{"key":"10.1016\/j.metabol.2025.156332_bb0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/jmcb\/mjaa046","article-title":"Induction of Wnt signaling antagonists and p21-activated kinase enhances cardiomyocyte proliferation during zebrafish heart regeneration","volume":"13","author":"Peng","year":"2021","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.metabol.2025.156332_bb0085","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev-physiol-021119-034332","article-title":"The osteocyte: new insights","volume":"82","author":"Robling","year":"2020","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.metabol.2025.156332_bb0090","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fendo.2018.00278","article-title":"Paracrine effects of FGF23 on the heart","volume":"9","author":"Leifheit-Nestler","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2025.156332_bb0095","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00016.2003","article-title":"FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization","volume":"285","author":"Quarles","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2025.156332_bb0100","article-title":"Physiology of FGF23 and overview of genetic diseases associated with renal phosphate wasting","volume":"103s","author":"Bacchetta","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156332_bb0105","article-title":"The relationship between Fibroblast Growth Factor 23 (FGF23) and cardiac MRI findings following primary PCI in patients with acute first time STEMI","volume":"33","author":"Thorsen","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.metabol.2025.156332_bb0110","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ehf2.12416","article-title":"Bone marrow and plasma FGF-23 in heart failure patients: novel insights into the heart-bone axis","volume":"6","author":"von Jeinsen","year":"2019","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.metabol.2025.156332_bb0115","doi-asserted-by":"crossref","first-page":"16744","DOI":"10.1038\/s41598-025-01334-2","article-title":"Klotho plasma levels are an independent predictorof mortality in women with acute coronary syndrome","volume":"15","author":"Cort\u00e9s","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2025.156332_bb0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41569-023-00903-0","article-title":"FGF23 and klotho at the intersection of kidney and cardiovascular disease","volume":"21","author":"Edmonston","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.metabol.2025.156332_bb0125","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.kint.2025.01.024","article-title":"Fibroblast growth factor 23 and fibroblast growth factor receptor 4 promote cardiac metabolic remodeling in chronic kidney disease","volume":"107","author":"Fuchs","year":"2025","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2025.156332_bb0130","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1210\/er.2017-00220","article-title":"X-linked hypophosphatemia and FGF23-related hypophosphatemic diseases: prospect for new treatment","volume":"39","author":"Kinoshita","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2025.156332_bb0135","article-title":"Diagnosis, treatment-monitoring and follow-up of children and adolescents with X-linked hypophosphatemia (XLH)","volume":"103s","author":"Rothenbuhler","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156332_bb0140","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(24)01305-9","article-title":"X-linked hypophosphataemia","volume":"404","author":"Kamenick\u00fd","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2025.156332_bb0145","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1210\/en.2018-00174","article-title":"Increased circulating FGF23 does not lead to cardiac hypertrophy in the male Hyp mouse model of XLH","volume":"159","author":"Liu","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2025.156332_bb0150","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgad608","article-title":"Reassuring data on the cardiovascular risk in adults with X-linked hypophosphatemia receiving conventional therapy","volume":"109","author":"Bouzemane","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2025.156332_bb0155","first-page":"20","article-title":"FGF23-mediated activation of local RAAS promotes cardiac hypertrophy and fibrosis","author":"B\u00f6ckmann","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2025.156332_bb0160","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.yjmcc.2019.11.149","article-title":"FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in mice","volume":"138","author":"Han","year":"2020","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.metabol.2025.156332_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.745892","article-title":"Cardiac fibroblast growth factor 23 excess does not induce left ventricular hypertrophy in healthy mice","volume":"9","author":"Leifheit-Nestler","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.metabol.2025.156332_bb0170","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.kint.2025.02.017","article-title":"Fibroblast growth factor (FGF) 23 and FGF receptor 4 induced cardiac mitochondrial dysfunction as a new target in CKD?","volume":"107","author":"Haffner","year":"2025","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2025.156332_bb0175","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.0000000710","article-title":"Network interactions of circulating FGF23, HRG-HMGB1, and cardiac disease in CKD","author":"Perwad","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2025.156332_bb0180","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024952","article-title":"Fibroblast growth factor 23 and risk of new onset heart failure with preserved or reduced ejection fraction: the PREVEND study","volume":"11","author":"Binnenmars","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2025.156332_bb0185","first-page":"103","article-title":"CA125, Galectin-3 and FGF-23 are interrelated in heart failure with reduced ejection fraction","volume":"34","author":"Gruson","year":"2023","journal-title":"Ejifcc"},{"key":"10.1016\/j.metabol.2025.156332_bb0190","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cardfail.2020.09.477","article-title":"Fibroblast growth factor 23 and exercise capacity in heart failure with preserved ejection fraction","volume":"27","author":"Ghuman","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.metabol.2025.156332_bb0195","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1002\/ehf2.13020","article-title":"Fibroblast-growth-factor-23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes","volume":"7","author":"Kanagala","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.metabol.2025.156332_bb0200","first-page":"7","article-title":"Fibroblast growth factor 23 in children with or without heart failure: a prospective study","author":"Elzayat","year":"2023","journal-title":"BMJ Paediatr Open"},{"key":"10.1016\/j.metabol.2025.156332_bb0205","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2147\/IJGM.S517028","article-title":"Serum FGF23 and DPP4 levels as biomarkers for coronary artery disease severity in type 2 diabetic patients with coronary heart disease","volume":"18","author":"Zhong","year":"2025","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.metabol.2025.156332_bb0210","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/ejhf.1749","article-title":"Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial","volume":"22","author":"St\u00f6hr","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.metabol.2025.156332_bb0215","article-title":"Fibroblast growth factor 23 and outcomes of atrial fibrillation: from clinical association to genetic evidence","author":"Li","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.metabol.2025.156332_bb0220","doi-asserted-by":"crossref","first-page":"19502","DOI":"10.1002\/jcp.28548","article-title":"FGF23 regulates atrial fibrosis in atrial fibrillation by mediating the STAT3 and SMAD3 pathways","volume":"234","author":"Dong","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.metabol.2025.156332_bb0225","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/eci.12296","article-title":"FGF-23 dysregulates calcium homeostasis and electrophysiological properties in HL-1 atrial cells","volume":"44","author":"Kao","year":"2014","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.metabol.2025.156332_bb0230","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1093\/ndt\/gfy392","article-title":"Fibroblast growth factor-23 promotes rhythm alterations and contractile dysfunction in adult ventricular cardiomyocytes","volume":"34","author":"Navarro-Garc\u00eda","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.metabol.2025.156332_bb0235","article-title":"Cardiac FGF23 increases intracellular calcium in atrial myocytes and the susceptibility to atrial fibrillation decreased in FGF23(f) (\/) (f)MyHC(Cre) (\/+) mice","volume":"29","author":"Li","year":"2025","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.metabol.2025.156332_bb0240","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40256-024-00688-8","article-title":"Vitamin D-parathyroid hormone-fibroblast growth factor 23 axis and cardiac remodeling","volume":"25","author":"Deng","year":"2025","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.metabol.2025.156332_bb0245","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41430-020-00725-0","article-title":"The effect of vitamin D on fibroblast growth factor 23: a systematic review and meta-analysis of randomized controlled trials","volume":"75","author":"Zittermann","year":"2021","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.metabol.2025.156332_bb0250","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jtcme.2023.02.007","article-title":"Protective role of vitamin D3 in a rat model of hyperthyroid-induced cardiomyopathy","volume":"13","author":"Salem","year":"2023","journal-title":"J Tradit Complement Med"},{"key":"10.1016\/j.metabol.2025.156332_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112002","article-title":"Lipocalin-2: structure, function, distribution and role in metabolic disorders","volume":"142","author":"Jaberi","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.metabol.2025.156332_bb0260","doi-asserted-by":"crossref","first-page":"E1023","DOI":"10.1152\/ajpendo.00586.2007","article-title":"Dexamethasone-induced expression of the glucocorticoid response gene lipocalin 2 in chondrocytes","volume":"294","author":"Owen","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2025.156332_bb0265","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature21697","article-title":"MC4R-dependent suppression of appetite by bone-derived lipocalin 2","volume":"543","author":"Mosialou","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2025.156332_bb0270","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.13504","article-title":"Lipocalin 2-a bone-derived anorexigenic and \u03b2-cell promoting signal: from mice to humans","volume":"16","author":"Yang","year":"2024","journal-title":"J Diabetes"},{"key":"10.1016\/j.metabol.2025.156332_bb0275","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4330\/wjc.v16.i12.720","article-title":"Independent prognostic value of lipocalin-2 in congenital heart disease-associated pulmonary artery hypertension","volume":"16","author":"Guo","year":"2024","journal-title":"World J Cardiol"},{"key":"10.1016\/j.metabol.2025.156332_bb0280","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/jbmr.2546","article-title":"Circulating lipocalin 2 levels predict fracture-related hospitalizations in elderly women: a prospective cohort study","volume":"30","author":"Lim","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2025.156332_bb0285","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41392-023-01635-w","article-title":"Macrophage CARD9 mediates cardiac injury following myocardial infarction through regulation of lipocalin 2 expression","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.metabol.2025.156332_bb0290","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00894-023-05825-9","article-title":"High-fat diet-induced LCN2 exacerbates myocardial ischemia-reperfusion injury by enhancing platelet activation","author":"Li","year":"2024","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.metabol.2025.156332_bb0295","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/jcp.24391","article-title":"Altered bone development and turnover in transgenic mice over-expressing lipocalin-2 in bone","volume":"228","author":"Costa","year":"2013","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.metabol.2025.156332_bb0300","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/jbmr.3406","article-title":"A complex role for Lipocalin 2 in bone metabolism: global ablation in mice induces osteopenia caused by an altered energy metabolism","volume":"33","author":"Capulli","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2025.156332_bb0305","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ejvs.2016.01.009","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) is associated with symptomatic carotid atherosclerosis and drives pro-inflammatory state in vitro","volume":"51","author":"Eilenberg","year":"2016","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.metabol.2025.156332_bb0310","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12933-025-02646-3","article-title":"BDH1 overexpression alleviates diabetic cardiomyopathy through inhibiting H3K9bhb-mediated transcriptional activation of LCN2","volume":"24","author":"Xu","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2025.156332_bb0315","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/01.ATV.0000193567.88685.f4","article-title":"Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction","volume":"26","author":"Hemdahl","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2025.156332_bb0320","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41419-024-07260-x","article-title":"Lipocalin-2 promotes CKD vascular calcification by aggravating VSMCs ferroptosis through NCOA4\/FTH1-mediated ferritinophagy","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.metabol.2025.156332_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103342","article-title":"Lipocalin-2 aggravates blood-brain barrier dysfunction after intravenous thrombolysis by promoting endothelial cell ferroptosis via regulating the HMGB1\/Nrf2\/HO-1 pathway","volume":"76","author":"Liu","year":"2024","journal-title":"Redox Biol"},{"key":"10.1016\/j.metabol.2025.156332_bb0330","first-page":"1339","article-title":"Lipocalin 2 induces self-limited inhibition of osteoblast differentiation of mesenchymal stem cells","volume":"43","author":"Chen","year":"2023","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.metabol.2025.156332_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1009726","article-title":"Lipocalin-2 participates in sepsis-induced myocardial injury by mediating lipid accumulation and mitochondrial dysfunction","volume":"9","author":"Liu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.metabol.2025.156332_bb0340","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/FJC.0000000000001590","article-title":"Mesenchymal stem cells alleviate mouse sepsis-induced cardiomyopathy by inhibiting the NR1D2\/LCN2 pathway","volume":"84","author":"Jiang","year":"2024","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.metabol.2025.156332_bb0345","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.yjmcc.2024.05.007","article-title":"Knockdown of LncRNA Lcn2-204 alleviates sepsis-induced myocardial injury by regulation of iron overload and ferroptosis","volume":"192","author":"Huang","year":"2024","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.metabol.2025.156332_bb0350","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2505119","article-title":"Faecalibacterium prausnitzii prevents age-related heart failure by suppressing ferroptosis in cardiomyocytes through butyrate-mediated LCN2 regulation","volume":"17","author":"Zhang","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.metabol.2025.156332_bb0355","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13717","article-title":"Lipocalin-2 induced LDHA expression promotes vascular remodelling in pulmonary hypertension","volume":"57","author":"Wang","year":"2024","journal-title":"Cell Prolif"},{"key":"10.1016\/j.metabol.2025.156332_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2024.117132","article-title":"PGC-1\u03b1\/LDHA signaling facilitates glycolysis initiation to regulate mechanically induced bone remodeling under inflammatory microenvironment","volume":"185","author":"Liu","year":"2024","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2025.156332_bb0365","doi-asserted-by":"crossref","first-page":"12543","DOI":"10.18632\/aging.206091","article-title":"DDIT3 switches osteogenic potential of BMP9 to lipogenic by attenuating Wnt\/\u03b2-catenin signaling via up-regulating DKK1 in mesenchymal stem cells","volume":"16","author":"Luo","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.metabol.2025.156332_bb0370","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jbmr.4809","article-title":"Multi-targeting DKK1 and LRP6 prevents bone loss and improves fracture resistance in multiple myeloma","volume":"38","author":"Simic","year":"2023","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2025.156332_bb0375","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.numecd.2022.10.007","article-title":"Correlation between serum Dickkopf-1 (DKK1) levels and coronary artery stenosis","volume":"33","author":"Xu","year":"2023","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.metabol.2025.156332_bb0380","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/eurheartj\/ehad842","article-title":"Inhibition of a novel Dickkopf-1-LDL receptor-related proteins 5 and 6 axis prevents diabetic cardiomyopathy in mice","volume":"45","author":"Ma","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2025.156332_bb0385","first-page":"701","article-title":"Platelet-derived growth factor subunit-B mediating the effect of dickkopf-1 on acute myocardial infarction risk: a two-step Mendelian randomization study","volume":"16","author":"Li","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.metabol.2025.156332_bb0390","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/ckj\/sfaa069","article-title":"Associations of serum sclerostin and Dickkopf-related protein-1 proteins with future cardiovascular events and mortality in haemodialysis patients: a prospective cohort study","volume":"14","author":"Stavrinou","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.metabol.2025.156332_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2022.111732","article-title":"Promising cardioprotective effect of baicalin in doxorubicin-induced cardiotoxicity through targeting toll-like receptor 4\/nuclear factor-\u03baB and Wnt\/\u03b2-catenin pathways","volume":"102","author":"El-Ela","year":"2022","journal-title":"Nutrition"},{"key":"10.1016\/j.metabol.2025.156332_bb0400","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.athoracsur.2020.08.068","article-title":"Wnt signaling mediates pro-fibrogenic activity in human aortic valve interstitial cells","volume":"112","author":"Jarrett","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.metabol.2025.156332_bb0405","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1111\/jcmm.15067","article-title":"LncRNA TUG1 alleviates cardiac hypertrophy by targeting miR-34a\/DKK1\/Wnt-\u03b2-catenin signalling","volume":"24","author":"Fang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.metabol.2025.156332_bb0410","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jcp.28964","article-title":"Long noncoding RNA MAGI1-IT1 regulates cardiac hypertrophy by modulating miR-302e\/DKK1\/Wnt\/beta-catenin signaling pathway","volume":"235","author":"Zhang","year":"2020","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.metabol.2025.156332_bb0415","doi-asserted-by":"crossref","first-page":"75","DOI":"10.14715\/cmb\/2023.69.10.10","article-title":"Effect of testosterone on the mRNA expression of Wnt-2 and dickkopf1 (DKK1), collagen deposition and oxidative stress in the cardiac tissue in male rats","volume":"69","author":"Ghowsi","year":"2023","journal-title":"Cell Mol Biol (Noisy-le-Grand)"},{"key":"10.1016\/j.metabol.2025.156332_bb0420","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s10020-024-00838-3","article-title":"Dickkopf-1 (DKK1) blockade mitigates osteogenesis imperfecta (OI) related bone disease","volume":"30","author":"Ko","year":"2024","journal-title":"Mol Med"},{"key":"10.1016\/j.metabol.2025.156332_bb0425","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1038\/s41467-019-13343-7","article-title":"Crystal structure and receptor-interacting residues of MYDGF - a protein mediating ischemic tissue repair","volume":"10","author":"Ebenhoch","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2025.156332_bb0430","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202153509","article-title":"Myeloid-derived growth factor (MYDGF) protects bone mass through inhibiting osteoclastogenesis and promoting osteoblast differentiation","volume":"23","author":"Xu","year":"2022","journal-title":"EMBO Rep"},{"key":"10.1016\/j.metabol.2025.156332_bb0435","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nm.3778","article-title":"Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction","volume":"21","author":"Korf-Klingebiel","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2025.156332_bb0440","first-page":"886","article-title":"Loss of myeloid-derived growth factor leads to increased fibrosis in mice after myocardial infarction","volume":"55","author":"Han","year":"2024","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.metabol.2025.156332_bb0445","doi-asserted-by":"crossref","first-page":"38429","DOI":"10.1021\/acsami.9b12043","article-title":"Injectable citrate-based hydrogel as an angiogenic biomaterial improves cardiac repair after myocardial infarction","volume":"11","author":"Yuan","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.metabol.2025.156332_bb0450","doi-asserted-by":"crossref","first-page":"9100","DOI":"10.7150\/thno.44281","article-title":"Mydgf promotes cardiomyocyte proliferation and neonatal heart regeneration","volume":"10","author":"Wang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.metabol.2025.156332_bb0455","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.120.053365","article-title":"Myeloid-derived growth factor protects against pressure overload-induced heart failure by preserving sarco\/endoplasmic reticulum ca(2+)-ATPase expression in cardiomyocytes","volume":"144","author":"Korf-Klingebiel","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2025.156332_bb0460","first-page":"7","article-title":"Myeloid-derived growth factor inhibits inflammation and alleviates endothelial injury and atherosclerosis in mice","author":"Meng","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.metabol.2025.156332_bb0465","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.123.319905","article-title":"Inflammatory cell-derived MYDGF attenuates endothelial LDL transcytosis to protect against atherogenesis","volume":"43","author":"Xu","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2025.156332_bb0470","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41401-023-01155-x","article-title":"Myeloid-derived growth factor suppresses VSMC dedifferentiation and attenuates postinjury neointimal formation in rats by activating S1PR2 and its downstream signaling","volume":"45","author":"Yang","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.metabol.2025.156332_bb0475","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12902-023-01462-8","article-title":"Association between serum osteocalcin and atherosclerosis in Type-2 diabetes mellitus: a cross-sectional study","volume":"23","author":"Sharma","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.metabol.2025.156332_bb0480","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jcmg.2022.03.018","article-title":"In vivo coronary (18)F-sodium fluoride activity: correlations with coronary plaque histological vulnerability and physiological environment","volume":"16","author":"Wen","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.metabol.2025.156332_bb0485","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3164\/jcbn.22-16","article-title":"25-hydroxyvitamin D-1\u03b1-hydroxylase (CYP27B1) induces ectopic calcification","volume":"71","author":"Yimamu","year":"2022","journal-title":"J Clin Biochem Nutr"},{"key":"10.1016\/j.metabol.2025.156332_bb0490","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/jbmr.3888","article-title":"Osteocalcin regulates arterial calcification via altered Wnt signaling and glucose metabolism","volume":"35","author":"Rashdan","year":"2020","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2025.156332_bb0495","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.897179","article-title":"A reproducible mouse model of moderate CKD with early manifestations of osteoblastic transition of cardiovascular system","volume":"13","author":"Machado","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.metabol.2025.156332_bb0500","first-page":"13","article-title":"Novel glycomimetics protect against glycated low-density lipoprotein-induced vascular calcification in vitro via attenuation of the RAGE\/ERK\/CREB pathway","author":"Sidgwick","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.metabol.2025.156332_bb0505","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1038\/s41467-021-25673-6","article-title":"Endothelium-specific depletion of LRP1 improves glucose homeostasis through inducing osteocalcin","volume":"12","author":"Mao","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2025.156332_bb0510","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bone.2016.11.024","article-title":"Sclerostin expression and functions beyond the osteocyte","volume":"96","author":"Weivoda","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2025.156332_bb0515","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.metabol.2017.10.005","article-title":"Genetics of Sost\/SOST in sclerosteosis and van Buchem disease animal models","volume":"80","author":"Sebastian","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2025.156332_bb0520","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1074\/mcp.M110.001693","article-title":"Proteomics characterization of extracellular space components in the human aorta","volume":"9","author":"Didangelos","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.metabol.2025.156332_bb0525","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.2217\/bmm-2021-0168","article-title":"Low vitamin K status, high sclerostin and mortality risk of stable coronary heart disease patients","volume":"15","author":"Mayer","year":"2021","journal-title":"Biomark Med"},{"key":"10.1016\/j.metabol.2025.156332_bb0530","first-page":"8822","article-title":"Serum sclerostin as a potential novel biomarker for heart valve calcification in patients with chronic kidney disease","volume":"22","author":"Ji","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.metabol.2025.156332_bb0535","article-title":"The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2025.156332_bb0540","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1210\/jc.2013-1521","article-title":"Sclerostin: another vascular calcification inhibitor?","volume":"98","author":"Claes","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2025.156332_bb0545","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.7150\/thno.63177","article-title":"Therapeutic aptamer targeting sclerostin loop3 for promoting bone formation without increasing cardiovascular risk in osteogenesis imperfecta mice","volume":"12","author":"Wang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.metabol.2025.156332_bb0550","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033038","article-title":"Reduced sclerostin expression in human atherosclerotic plaques links to ischemic stroke","volume":"13","author":"Burger","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2025.156332_bb0555","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jbmr.4467","article-title":"Circulating sclerostin levels are positively related to coronary artery disease severity and related risk factors","volume":"37","author":"Frysz","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2025.156332_bb0560","article-title":"Association of total and bioactive serum sclerostin levels with bone metabolism in type 2 diabetes mellitus","volume":"40","author":"Traechslin","year":"2025","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.metabol.2025.156332_bb0565","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12933-024-02406-9","article-title":"Bone proteins are associated with cardiovascular risk according to the SCORE2-Diabetes algorithm","volume":"23","author":"Gonz\u00e1lez-Salvatierra","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2025.156332_bb0570","first-page":"134","article-title":"Increased endothelial sclerostin caused by elevated DSCAM mediates multiple trisomy 21 phenotypes","author":"McKean","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2025.156332_bb0575","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.21037\/jtd-22-473","article-title":"Sclerostin aggravates cardiac remodeling after myocardial infarction by inhibition of Wnt\/\u03b2-catenin signaling pathway","volume":"14","author":"Zheng","year":"2022","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.metabol.2025.156332_bb0580","article-title":"Romosozumab for the treatment of osteoporosis in women: efficacy, safety, and cardiovascular risk","volume":"18","author":"Lim","year":"2022","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.metabol.2025.156332_bb0585","doi-asserted-by":"crossref","first-page":"H1037","DOI":"10.1152\/ajpheart.00355.2022","article-title":"Sclerostin ablation prevents aortic valve stenosis in mice","volume":"323","author":"Joll","year":"2022","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2025.156332_bb0590","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014816","article-title":"Associations of serum Dickkopf-1 and sclerostin with cardiovascular events: results from the prospective Bruneck study","volume":"9","author":"Klingenschmid","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2025.156332_bb0595","first-page":"12","article-title":"Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics","author":"Bovijn","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.metabol.2025.156332_bb0600","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.revmed.2023.07.003","article-title":"Jejuno-ileal fold pattern reversal","volume":"45","author":"El Adioui","year":"2024","journal-title":"Rev Med Interne"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604952500201X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604952500201X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:49:18Z","timestamp":1778564958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002604952500201X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":120,"alternative-id":["S002604952500201X"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156332","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The bone-heart axis: A crucial dialogue in cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156332"}}